All In MedTech

Device Trial Radar · NCT07745647

Voll Non-Degradable Shoulder Spacer FIH Study

A Single-Center, Prospective, First-In-Human Study to Evaluate the Initial Safety and Effectiveness of a Non-Degradable Shoulder Spacer in Patients With Symptomatic Massive Rotator Cuff Tears

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Sep 2027

Study completion Sep 2028

Sponsor

Lead sponsor
Voll Medical Technologies Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Aug 4, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Conditions

  • Massive Rotator Cuff Tears
  • Massive Rotator Cuff Tear

Interventions

  • Voll Non-Degradable Shoulder SpacerDevice

    Voll Non-Degradable Shoulder Spacer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device-related Serious Adverse EventsTime frame: Up to 12 months post-implantation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Assuta Ashdod Hospital

    Ashdod, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.